Simon Woelfel

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Anti-Integrin αvβ6 Autoantibodies Distinguish Ulcerative Colitis From Crohn's Disease With High Diagnostic Accuracy and Outperform ANCA and ASCA Status: A Prospective Cross-Sectional Study.

Anti-Integrin αvβ6 Autoantibodies Distinguish Ulcerative Colitis From Crohn's Disease With High Diagnostic Accuracy and Outperform ANCA and ASCA Status: A Prospective Cross-Sectional Study.

Journal: Alimentary pharmacology & therapeutics
Published: June 12, 2026

Epigenetic modulation of stromal cell states underpins pathological tissue niches in Crohn's disease.

Epigenetic modulation of stromal cell states underpins pathological tissue niches in Crohn's disease.

Journal: Nature immunology
Published: August 07, 2025

XBB.1.5 COVID-19 mRNA Vaccines Induce Inadequate Mucosal Immunity in Patients with Inflammatory Bowel Disease.

XBB.1.5 COVID-19 mRNA Vaccines Induce Inadequate Mucosal Immunity in Patients with Inflammatory Bowel Disease.

Journal: Vaccines
Published: May 24, 2025

Editorial: Individualising JAK Inhibitor Selection for Patients With Ulcerative Colitis.

Editorial: Individualising JAK Inhibitor Selection for Patients With Ulcerative Colitis.

Journal: Alimentary pharmacology & therapeutics
Published: December 09, 2024

Editorial: Updated COVID-19 Boosters-Tailoring Protection for Patients With IBD. Authors' Reply.

Editorial: Updated COVID-19 Boosters-Tailoring Protection for Patients With IBD. Authors' Reply.

Journal: Alimentary pharmacology & therapeutics
Published: November 06, 2024

STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease.

STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease.

Journal: Vaccines
Published: October 02, 2024

XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel Disease.

XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel Disease.

Journal: Alimentary pharmacology & therapeutics
Published: August 28, 2024

Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease.

Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease.

Journal: Vaccines
Published: June 07, 2024

Intestinal colonization resistance in the context of environmental, host, and microbial determinants.

Intestinal colonization resistance in the context of environmental, host, and microbial determinants.

Journal: Cell host & microbe
Published: February 15, 2024

STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease.

STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease.

Journal: Alimentary pharmacology & therapeutics
Published: July 03, 2023

Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2.

Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2.

Journal: Alimentary pharmacology & therapeutics
Published: August 23, 2022

Pulsed antibiotic treatments of gnotobiotic mice manifest in complex bacterial community dynamics and resistance effects.

Pulsed antibiotic treatments of gnotobiotic mice manifest in complex bacterial community dynamics and resistance effects.

Journal: Cell host & microbe
Published: June 28, 2022
Showing 1-12 of 15

Last Updated: 09/26/2026